Cargando…
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET
To assess the ability of [(18)F]fluorodeoxyglucose positron emission tomography for the early prediction of response in patients with relapsed metastatic germ cell tumours undergoing salvage high-dose chemotherapy. The role of positron emission tomography was compared with established means of tumou...
Autores principales: | Bokemeyer, C, Kollmannsberger, C, Oechsle, K, Dohmen, B M, Pfannenberg, A, Claussen, C D, Bares, R, Kanz, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375283/ https://www.ncbi.nlm.nih.gov/pubmed/11870528 http://dx.doi.org/10.1038/sj.bjc.6600122 |
Ejemplares similares
-
Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
por: Kollmannsberger, C, et al.
Publicado: (2003) -
How [18F]-FDG-PET/CT Affects Clinical Management of Patients with Germ Cell Tumors in the Real World
por: Liang, Cecilia, et al.
Publicado: (2023) -
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
por: Kollmannsberger, C, et al.
Publicado: (2002) -
Treatment outcome after radiochemotherapy in anal cancer patients staged with (18)F-FDG-PET-CT
por: Braun, L.H., et al.
Publicado: (2020) -
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
por: Bokemeyer, C, et al.
Publicado: (2003)